Tag:
Latest Headlines
Latest Headlines
Eli Lilly targets journos on Twitter and Facebook as pharma coverage goes social
In recent weeks, Eli Lilly has been flexing its social media muscles in an effort reach out to journalists on the popular platforms of Facebook and Twitter.
Facebook goes biotech for new board member
Facebook CEO and founder Mark Zuckerberg has sought out a top Genentech alum for the social media giant's board of directors.
Could playing mobile phone games help advance cancer cures?
Over the weekend cancer researchers and tech aces from Google and other companies teamed up to quickly blueprint a mobile game to advance research of tumor genes. It's one of the latest in a spate of missions to crowdsource tech talent and employ average citizens to take on scientific challenges.
Facebook, Google geeks 'hack' into cancer research problem with mobile game
Playing video games on mobile devices could help researchers solve riddles in mountains of genetic tumor data. And Cancer Research UK has enlisted programming talent from Amazon Web Services, Facebook and Google to help craft a mobile game to make video game players into "citizen scientists."
FDA grants further glimpse into pharma's Facebook perils
Pharma now has another hint about FDA's attitudes toward social media. In a recent warning letter to supplement maker AMARC Enterprises, FDA took issue with the company's use of Facebook's "Like" feature. Apparently, the company "Liked" a questionable user testimonial--and the agency didn't like it.
What Facebook and Google billionaires could do for overlooked biotech brains
Americans are more likely to know the names of Tom Brady's kids than the names of the last couple of scientists to win Nobel prizes in medicine. That's because our fame-infatuated culture...
Biotech, pharma warming up to Facebook
With more than 1 billion users plugged in, Facebook has huge potential to have a real impact on science and public health, beyond just a marketing platform for biotech and pharma companies.
Boehringer caps pharma social media blitz with new blog
Boehringer Ingelheim has rolled out a new blog as the German drugmaker travels yet another avenue of social media. The company has tapped just about every major social media platform and in September launched the online pharma game "Syrum" on Facebook.
Survey: Pharma's social media, mobile use spreads in 2012
Attention pharma workers reading this story on an iPad with plans to tweet it: You're not alone in your consumption of mobile tech and social media.
Pfizer wins popularity contest in social media survey of patients
But the survey of 356 patients showed that 47% of them had a negative opinion of pharma companies in general compared with 30% of advocates with overall favorable views on drugmakers.
